Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

arginase deficiency News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study published in PubMed highlights the prevalence, disease onset, and clinical outcomes of arginase 1 deficiency across Germany, Austria, and Switzerland. This cross-border surveillance provides valuable insights into the disease's impact on affected individuals.

A novel hybrid piggyBac AAV-transposon and LNP-transposase system demonstrates a 100-fold dose reduction for treating arginase deficiency compared to traditional AAV methods. This breakthrough could enhance treatment efficacy and reduce costs for patients.

A recent study published in PubMed provides insights into the clinical characteristics and natural history of arginase 1 deficiency, based on data from international clinical trials. This research enhances understanding of the disease's progression and patient outcomes.

Not rare diseases news,news about your rare disease.

Earlier

A recent study published in PubMed highlights the prevalence, disease onset, and clinical outcomes of arginase 1 deficiency across Germany, Austria, and Switzerland. This cross-border surveillance provides valuable insights into the disease's impact on affected individuals.

A novel hybrid piggyBac AAV-transposon and LNP-transposase system demonstrates a 100-fold dose reduction for treating arginase deficiency compared to traditional AAV methods. This breakthrough could enhance treatment efficacy and reduce costs for patients.

A recent study published in PubMed provides insights into the clinical characteristics and natural history of arginase 1 deficiency, based on data from international clinical trials. This research enhances understanding of the disease's progression and patient outcomes.

Not rare diseases news,
news about your rare disease.